Diabetes and the risk of infections with immunomodulator therapy in inflammatory bowel diseases

E-ISSN： 1365-2036|41|11|1141-1148

ISSN： 0269-2813

Source： ALIMENTARY PHARMACOLOGY & THERAPEUTICS, Vol.41, Iss.11, 2015-06, pp. : 1141-1148

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Editorial: diabetes and the risk of infections with immunomodulator therapy in inflammatory bowel diseases

ALIMENTARY PHARMACOLOGY & THERAPEUTICS, Vol. 42, Iss. 1, 2015-07 ,pp. : 119-120

John Wiley & Sons Inc

Access to resources Recommend Favorite

Editorial: diabetes and the risk of infections with immunomodulator therapy in inflammatory bowel diseases – author's reply

ALIMENTARY PHARMACOLOGY & THERAPEUTICS, Vol. 42, Iss. 1, 2015-07 ,pp. : 120-120

John Wiley & Sons Inc

Access to resources Recommend Favorite

Letter: diverticulosis in inflammatory bowel diseases

ALIMENTARY PHARMACOLOGY & THERAPEUTICS, Vol. 39, Iss. 8, 2014-04 ,pp. : 899-900

John Wiley & Sons Inc

Access to resources Recommend Favorite

Irradiation Toxicity and Inflammatory Bowel Diseases (IBD): Review

Reviews on Recent Clinical Trials, Vol. 9, Iss. 1, 2014-03 ,pp. : 31-36

Bentham Science Publishers

Access to resources Recommend Favorite

New strategies for the treatment of inflammatory bowel diseases

By Roblin Xavier Dronne William Paul Stéphane Tedesco Emilie Del

Clinical Investigation, Vol. 3, Iss. 5, 2013-05 ,pp. : 479-492

Future Science

Access to resources Recommend Favorite